246 related articles for article (PubMed ID: 28118722)
1. [Ovarian Ablation in Breast Cancer Patients and the Possibility of Influencing Treatment Side Effects].
Palácová M
Klin Onkol; 2016; 29 Suppl 3():S29-38. PubMed ID: 28118722
[TBL] [Abstract][Full Text] [Related]
2. [Treatment with Aromatase Inhibitors in Postmenopausal Women with Breast Cancer and the Possibility of Influencing Side Effects].
Krásenská M
Klin Onkol; 2016; 29 Suppl 3():S39-49. PubMed ID: 28118723
[TBL] [Abstract][Full Text] [Related]
3. Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause.
Nourmoussavi M; Pansegrau G; Popesku J; Hammond GL; Kwon JS; Carey MS
Cancer Treat Rev; 2017 Apr; 55():26-35. PubMed ID: 28288389
[TBL] [Abstract][Full Text] [Related]
4. Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms.
Stearns V
Treat Endocrinol; 2006; 5(2):83-7. PubMed ID: 16542048
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations.
L'Espérance S; Frenette S; Dionne A; Dionne JY;
Support Care Cancer; 2013 May; 21(5):1461-74. PubMed ID: 23435567
[TBL] [Abstract][Full Text] [Related]
6. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
[TBL] [Abstract][Full Text] [Related]
7. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.
Cobin RH; Goodman NF;
Endocr Pract; 2017 Jul; 23(7):869-880. PubMed ID: 28703650
[TBL] [Abstract][Full Text] [Related]
8. Hormone Therapy and Other Treatments for Symptoms of Menopause.
Hill DA; Crider M; Hill SR
Am Fam Physician; 2016 Dec; 94(11):884-889. PubMed ID: 27929271
[TBL] [Abstract][Full Text] [Related]
9. Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.
Taleghani SY; Etesam F; Esfandbod M
Drug Res (Stuttg); 2023 Oct; 73(8):465-472. PubMed ID: 37647930
[TBL] [Abstract][Full Text] [Related]
10. [Non-hormonal alternatives for the management of menopausal hot flushes. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
Raccah-Tebeka B; Boutet G; Plu-Bureau G
Gynecol Obstet Fertil Senol; 2021 May; 49(5):373-393. PubMed ID: 33757925
[TBL] [Abstract][Full Text] [Related]
11. Management of hot flashes in breast cancer survivors and men with prostate cancer.
Stearns V
Curr Oncol Rep; 2004 Jul; 6(4):285-90. PubMed ID: 15161582
[TBL] [Abstract][Full Text] [Related]
12. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.
Bordeleau L; Pritchard K; Goodwin P; Loprinzi C
Clin Ther; 2007 Feb; 29(2):230-41. PubMed ID: 17472816
[TBL] [Abstract][Full Text] [Related]
14. Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.
Baber R; Hickey M; Kwik M
Drug Saf; 2005; 28(12):1085-100. PubMed ID: 16329712
[TBL] [Abstract][Full Text] [Related]
15. Management of Menopausal Symptoms: A Review.
Crandall CJ; Mehta JM; Manson JE
JAMA; 2023 Feb; 329(5):405-420. PubMed ID: 36749328
[TBL] [Abstract][Full Text] [Related]
16. Managing Menopausal Symptoms: Common Questions and Answers.
Chang JG; Lewis MN; Wertz MC
Am Fam Physician; 2023 Jul; 108(1):28-39. PubMed ID: 37440735
[TBL] [Abstract][Full Text] [Related]
17. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
19. The pharmacological and hormonal therapy of hot flushes in breast cancer survivors.
Wiśniewska I; Jochymek B; Lenart-Lipińska M; Chabowski M
Breast Cancer; 2016 Mar; 23(2):178-82. PubMed ID: 26498637
[TBL] [Abstract][Full Text] [Related]
20. Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
Davari-Tanha F; Soleymani-Farsani M; Asadi M; Shariat M; Shirazi M; Hadizadeh H
Arch Gynecol Obstet; 2016 May; 293(5):1007-13. PubMed ID: 26437957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
